Loading organizations...

Chinova Bioworks is a technology company.
Chinova Bioworks has raised $9.5M across 3 funding rounds.
Chinova Bioworks has raised $9.5M in total across 3 funding rounds.
Chinova Bioworks leads the way in harnessing the protective power of mushrooms, delivering solutions that reduce food waste, promote sustainability, and improve product freshness for consumers and producers alike.
Chinova Bioworks has raised $9.5M in total across 3 funding rounds.
Chinova Bioworks's investors include Bernard Lupien, Alberto Roca, Michael Dean, Natural Products Canada, Rhapsody Venture Partners.
Chinova Bioworks is a Canadian bio-foodtech company that develops natural, clean-label preservatives from white button mushrooms to extend shelf life in food and beverages.[1][2][3] Its flagship product, Chiber, is a tasteless, odorless, high-fiber extract derived from upcycled mushroom stems, serving food and beverage manufacturers by replacing artificial preservatives with a sustainable alternative that combats bacteria, yeast, and mold while reducing food waste.[1][3][4] The company targets the $2B preservatives market, with applications in sauces, spreads, beverages, and beyond, backed by trials with major global firms and partnerships like DSM.[1][4]
Founded in 2016 and headquartered in Fredericton, New Brunswick, Chinova has raised $10.5M in funding and employs a mostly women-led STEM team, showing strong growth through product expansions like MycoKleer for beverages and ongoing innovations.[2][4][6]
Chinova Bioworks was founded in 2016 by Natasha Dhayagude (CEO), David Brown (COO and technology inventor), and Dr. Tanzina Huq (CTO), who met at an entrepreneurship accelerator in New Brunswick.[1][3] Driven by sustainability and mushrooms' untapped potential, they partnered with farmers to upcycle discarded white button mushroom stems—a common byproduct—into a patented green-chemistry process for natural preservatives.[3][5]
Early traction came from the RebelBio accelerator, extensive R&D securing regulatory approvals, and credibility from awards like David Brown's 2017 Governor General Award.[1][3] This led to the launch of Chiber, with pivotal moments including trials by global food companies and expansions into new categories like sauces and beverages.[1][4]
Chinova rides the clean-label and sustainability wave in foodtech, where consumers demand natural ingredients amid rising artificial preservative scrutiny, especially in high-spoilage categories like sauces and beverages.[4] Timing aligns with mushroom innovation hype, upcycling trends to cut the 40% global food waste, and regulatory pushes for eco-friendly solutions in a $2B preservatives market.[1][3][5]
Market forces favor it: growing B2B demand from grocers and brands for shelf-stable, nutritious products; expansions into packaging tech and grocery retail ecosystems; and influences like reduced spoilage costs for retailers and global supply chain resilience.[2][4][6] Chinova shapes the ecosystem by pioneering fungal biotech, inspiring waste-to-value models and enabling brands to meet health-conscious demands without synthetic chemicals.[1][7]
Chinova is poised for scaled growth through Chiber expansions, new functional mushroom ingredients (potentially launching early 2024 onward), and international rollouts via partners like DSM.[1][2] Trends like clean-label mandates, mushroom functional foods, and food waste regulations will propel it, with multi-vertical opportunities in cosmetics and medical amplifying revenue.
Its influence may evolve from niche innovator to supply-chain staple, empowering global food security and sustainability—transforming mushroom waste into a preservative powerhouse that started with three founders' accelerator spark.[3][4]
Chinova Bioworks has raised $9.5M across 3 funding rounds. Most recently, it raised $6.0M Series A in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 22, 2022 | $6.0M Series A | Bernard Lupien | Alberto Roca |
| Feb 15, 2022 | $1.5M Other Equity | ||
| Aug 9, 2018 | $2.0M Seed | Michael Dean, Natural Products Canada, Rhapsody Venture Partners |